
To define a maximum tolerable dose, zzso zzso zzso was given as a zzso infusion every 28 days to cancer patients for whom no effective standard therapy was zzso zzso were escalated in zzso of at least three patients zzso Plasma for characterization of the zzso of free and total zzso was obtained during and after the initial infusion and, when possible, during and after subsequent infusions of zzso if the dose had been zzso A total of 101 courses of zzso in 55 patients were zzso zzso levels ranged from 18 to 3,700 zzso The zzso toxicity was zzso first recognized at the zzso zzso When zzso zzso was zzso patients were entered at successively lower doses, with close monitoring of plasma zzso and insulin zzso being done in 26 zzso Grade 1-3 zzso occurred within 4 h of the termination of zzso infusion and cleared by 24 zzso zzso zzso was more frequent at doses of zzso above 1,000 zzso zzso administration of zzso zzso did not zzso the zzso associated with zzso doses of zzso 1,000 zzso The total calorie zzso percentage of ideal body weight, or percentage of weight lost did not explain the zzso or severity of zzso in 12 patients in whom these data were zzso zzso zzso occurred in 7 patients who received zzso at doses of zzso or zzso 1,000 zzso and zzso was associated with zzso in 3 zzso Other zzso were zzso but the frequency of toxicity was higher at zzso doses of zzso or zzso 1,000 zzso These zzso included fever, zzso zzso zzso zzso zzso zzso zzso and zzso All zzso were zzso Mean peak plasma zzso and zzso increased with dose, with a suggestion that peak plasma zzso zzso at higher zzso The decline in plasma zzso was fitted to a zzso open linear zzso The terminal zzso ranged from 28 to 206 zzso Total body clearance ranged from 44 to zzso zzso with no evidence of zzso zzso zzso of the parent compound in 24 h averaged zzso zzso zzso not bound to plasma protein zzso zzso comprised zzso of total plasma zzso and was not related to zzso A relationship was defined between the magnitude of zzso and zzso zzso zzso The percentage of decrease in plasma zzso zzso zzso zzso zzso zzso zzso 100, correlated with both free and total peak plasma zzso zzso AT 400 zzso 

